Similar articles

• [Antithrombogenic therapy based on the study of the changes in platelet aggregability and blood coagulability in the early period after prosthetic valve replacement].

  Takayama T. Takayama T. Nihon Kyobu Geka Gakkai Zasshi. 1985 Jan;33(1):14-24. Nihon Kyobu Geka Gakkai Zasshi. 1985. PMID: 3998524 Japanese. No abstract available.
• [Blood coagulation after replacement of heart valves--cases with relatively early administration of anticoagulants].

  Nagasaki Y. Nagasaki Y. Igaku Kenkyu. 1974 Aug;44(5):461-80. Igaku Kenkyu. 1974. PMID: 4478043 Japanese. No abstract available.
• [Thrombosis of the Björk-Shiley valve as an early fatal complication of the prothetic aortic valve replacement (author's transl)].

  Stambolis C, Schwarze EW, Harke H, Nemsmann B, Bernhard A. Stambolis C, et al. Thoraxchir Vask Chir. 1975 Apr;23(2):160-5. doi: 10.1055/s-0028-1096939. Thoraxchir Vask Chir. 1975. PMID: 1079978 German.
• [Thrombosis prevention and platelet functions following heart valve replacement].

  Aosaki M, Kitamura N. Aosaki M, et al. Nihon Rinsho. 1978 Dec 10;36(12):3874-83. Nihon Rinsho. 1978. PMID: 372627 Review. Japanese. No abstract available.
• Platelet inhibitors in the treatment of thrombosis.

  Hirsh J. Hirsh J. Clin Invest Med. 1978;1(3-4):191-206. Clin Invest Med. 1978. PMID: 391458 Review. No abstract available.